Consolidated Statement of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Operating expenses:
Research and development	$ 13,966,368	$ 9,509,055
General and administrative	4,639,928	1,287,656
Change in fair value of convertible affiliated note	9,752,295	3,840,475
Operating loss	(28,358,591)	(14,637,186)
Other expense, net:
Interest expense	(2,431,614)	(2,440,903)
Gain on extinguishment of debt	355,515
Other income, net	221,920	839,191
Net loss	$ (30,212,770)	$ (16,238,898)
Per common share data:
Basic and diluted net loss per common share	$ (1.16)	$ (0.67)
Weighted average number of common shares outstanding	26,025,489	24,108,316
Other comprehensive gain (loss)
Foreign currency translation gain (loss)	$ 897,769	$ (1,390,448)
Comprehensive loss	$ (29,315,001)	$ (17,629,346)